Drugs / Iodine-Potassium Iodide
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT04856488 | Nov 2021 → Aug 2028 expected | hyperthyroidism | Jan Calissendorff | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Iodine-Potassium Iodide | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04856488 ↗ |
| Route | Oral | “Iodine Potassium Iodide 5% oral solution, administered 3 times per day for 10 days” NCT04856488 ↗ |